Therapeutic Asset Ratings

1,055 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
GEH300079 (68Ga) Colorectal Cancer	GE Healthcare	P2/3	CCC (48)
hr070803 Colorectal Cancer	Jiangsu HengRui Medicine Co., Ltd.	P2/3	CCC (48)
iah0968 Neoplasm	SUNHO（China）BioPharmaceutical CO., Ltd.	P2/3	CCC (48)
Immunoglobulin G4 [234-Proline], Anti-(Human Protein Garp-Transforming Growth Factor ?1 Complex) (Human Monoclonal Abbv-151 ?4-Chain), Disulfide With Human Monoclonal Abbv-151 ?-Chain, Dimer Non-Small Cell Lung Carcinoma	AbbVie	P2/3	CCC (48)
Rivogenlecleucel Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	CCC (48)
SACUBITRIL Obesity Disorder	University of Alabama at Birmingham	P2/3	CCC (48)
Silymarin Breast Cancer	Tanta University	P2/3	CCC (48)
Syhx2011 Non-Small Cell Lung Carcinoma	Shanghai Chest Hospital	P2/3	CCC (48)
Tegafur Cancer	University of Malaya	P2/3	CCC (48)
Triptoreline Prostate Cancer	Universitaire Ziekenhuizen KU Leuven	P2/3	CCC (48)
Umbralisib Mantle Cell Lymphoma	Yazeed Sawalha	P2/3	CCC (48)
Zilongjin Non-Small Cell Lung Carcinoma	Kong Fanming	P2/3	CCC (48)
Dasatinib Obesity Disorder	Cedars-Sinai Medical Center	P2/3	CC (47)
IMMUNOGLOBULIN G1, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN MONOCLONAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER Familial Alzheimer Disease	Washington University School of Medicine	P2/3	CC (46)
IMMUNOGLOBULIN G1, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN MONOCLONAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER Dementia	Washington University School of Medicine	P2/3	CC (46)
Capmatinib Gastric Cancer	Cancer Research UK	P2/3	CC (45)
Alflutinib Non-Small Cell Lung Carcinoma	The First Affiliated Hospital of Henan University of Science and Technology	P2/3	CC (44)
Rivogenlecleucel Myelodysplastic Syndrome	Fred Hutchinson Cancer Center	P2/3	CC (44)
Dipraglurant Parkinson Disease	Addex Pharma S.A.	P2/3	CC (42)
Dipraglurant Tardive Dyskinesia	Addex Pharma S.A.	P2/3	C (38)
Dipraglurant Drug-Induced Dyskinesia	Addex Pharma S.A.	P2/3	C (38)
Sasanlimab Non-Small Cell Lung Carcinoma	Pfizer	P2/3	C (38)
Luveltamab Tazevibulin Ovarian Carcinoma	Sutro Biopharma, Inc.	P2/3	D (30)
Luveltamab Tazevibulin Fallopian Tube Cancer	Sutro Biopharma, Inc.	P2/3	D (30)
Luveltamab Tazevibulin Ovarian Cancer	Sutro Biopharma, Inc.	P2/3	D (30)

Showing 1001 to 1025 of 1,055 assets

PreviousPage 41 of 43Next